Abstract
Recent studies have shown that growth hormone (GH) deficiency may deteriorate post-ischemic myocardial reperfusion damage. Furthermore, GH has been reported to be a promising therapeutic option in the treatment of chronic myocardial dysfunction. However, the exact mechanisms of action of GH on the cardiovascular system, particularly in the acute setting, are still unclear. The aim of our study consisted of monitoring the acute effects of GH infusion on isolated blood-perfused rabbit heart according to dose-response pattern and during ischemic conditions to test its anti-ischemic property. Seven blood-donors perfused isolated hearts were used as experimental model. The mechanical and metabolic data of the isolated organs were continuously monitored. Under aerobic conditions, dose-response curves were initially tested after intracoronary infusion of GH at increasing dosages (1, 2, 3 mg/l). After a stabilization period, the effects of GH infusion (5 mg/kg) administered 30 minutes prior to acute global myocardial ischemia (30 minutes) were also investigated. At the doses tested, GH did not induce any changes either in the developed or in the diastolic pressures of the isolated organ. However, transient reduction of the coronary perfusion pressure was observed at the dosage of 3 mg/l. During the ischemia/reperfusion study, at the dosages used in this study, GH did not modify either the degree of stunning in the early reperfusion or the recovery of the developed pressure at the end of reperfusion. In addition, GH did not prevent either the increase of diastolic pressure during ischemia or the release of lactate and CPK during reperfusion. Tissue content of high-energy phosphates was also not changed by GH infusion. In our experimental model, acute GH infusion did not reduce the ischemic/reperfusion damage of the myocardium. However, GH transiently induced coronary vasodilation without modifying the myocardial contractility. Acute effects of GH appear, therefore, to predominantly relate to vascular dilation suggesting that the effects on myocardial contractility may require long-lasting intake being likely linked to enhancement of specific protein synthesis or gene expression of cardiac myocytes.
Similar content being viewed by others
References
Volterrani M., Manelli F., Cicoira M., Lorusso R., Giustina A. Role of growth hormone in chronic heart failure. Drugs 2000, 60: 711–719.
Yang R., Bunting S., Gillet N., Clark R., Hongkui J. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995, 92: 262–267.
Rossoni G., De Gennaro M., Colonna V. et al. Protective activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J. Cardiovasc. Pharmacol. 1998, 32: 260–265.
Giustina A., Lorusso R., Borghetti V., Bugari G., Misitano V., Alfieri O. Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am. Heart J. 1996, 131: 620–622.
Pasini E., Solfrini R., Bachetti T. et al. The blood perfused isolated heart: characterization of the model. Basic Res. Cardiol. 1999, 94: 215–222.
Volterrani M., Desenzani P., Lorusso R., D’Aloia A., Manelli F., Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1997, 349: 1067–1068.
Fazio S., Sabatini D., Capaldo B. et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 1999, 334: 809–814.
Manelli F., Volterrani M., Lorusso R., Romanelli G., Giustina A. Acute growth hormone effects in human subjects with heart failure. In: Giustina A. (Ed.), Growth hormone and the heart. Kluwer Academic Publisher, 2000, 87–96.
Houck W.V., Pan L.C., Kribbs S.B. et al. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 1999, 100: 2003–2009.
Kinugawa S., Tsutsui H., Ide T. et al. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc. Res. 1999, 43: 157–164.
Broglio F., Benso A., Valetto M.R. et al. Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. Endocrine 2001, 14: 105–108.
Giustina A., Volterrani M., Manelli F. et al. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am. Heart J. 1999, 137: 1035–1043.
Anker S., Volterrani M., Pflaum C.D. et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J. Am. Coll. Cardiol. 2001, 443–452.
Giustina A., Veldhuis J. Pathophysiology of the neuroregulations of growth hormone secretion in experimental and the human. Endocr. Rev. 1998, 19: 717–797.
Capaldo B., Guardasole V., Pardo F. et al. Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001, 103: 520–524.
Grimm D., Cameron D., Griese P.G., Riegger G.A.J., Kromer E.P. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc. Res. 1998, 40: 297–306.
Isgaard J., Bergh C.H., Caidahl K., Lomsky M., Hjalmarson A., Bengtsson B.A. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur. Heart J. 1998, 19: 1704–1711.
Osterziel K.J., Strohm O., Schuler J. et al. Randomised, doubleblind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998, 351: 1233–1237.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lorusso, R., Pasini, E., Cargnoni, A. et al. Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. J Endocrinol Invest 26, RC1–RC4 (2003). https://doi.org/10.1007/BF03345113
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345113